Sacklers Pressed At House Hearing To Return Billions Withdrawn From Purdue
Executive Summary
Sackler family members were excoriated for taking $10.4 bn from Purdue after 2007 settlement with the DOJ but it seems unlikely the hearing will have an impact on bankruptcy proceedings. Asked to forego $3m bonus, Purdue CEO says he has already made "significant monetary concessions.”
You may also be interested in...
Purdue's $8.3bn Settlement With DOJ Requires Reconstitution As Public Benefit Company
Purdue pleads guilty to three felony charges over marketing of OxyContin under settlement that requires Purdue to be dissolved and transformed into an entity that provides addiction and overdose medicines. Twenty-five state AGs oppose creation of a PBC, arguing Purdue should be sold to another company.
Woodcock Faces Maze Of Rules To Become Commissioner Nominee
If Biden administration wants to nominate the acting commissioner, Vacancies Reform Act would dictate the timing. Woodcock can still get the nod and remain head of the agency during the confirmation process, just as Andrew von Eschenbach retained his acting title following his nomination in 2006.
FTC Commissioner Changes Could Impact Pharma Mergers, Scrutiny Of Biosimilars Uptake
President Biden’s picks to fill two commissioner posts may shift dynamics on pharmaceutical industry enforcement. Rohit Chopra’s nomination to Consumer Financial Protection Bureau removes strong critic of pharma mergers.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: